S. Ablan

发表

The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion

Ji Ming Wang, R. Blumenthal, Mathias Viard, 2006, Virology Journal.

A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.

K. Nagashima, E. Freed, I. Hewlett, 2007, Virology.

Impact of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457)

E. Freed, Kayoko Waki, K. Salzwedel, 2009, Journal of Virology.

Entry of influenza virus into a glycosphingolipid-deficient mouse skin fibroblast cell line

R. Blumenthal, A. Puri, S. Ablan, 2001, Archives of Virology.

Structural and Mechanistic Studies of the Rare Myristoylation Signal of the Feline Immunodeficiency Virus.

M. Summers, E. Freed, S. Ablan, 2020, Journal of molecular biology.

Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.

K. Nagashima, S. Lockett, E. Freed, 2004, Proceedings of the National Academy of Sciences of the United States of America.

TIM-family proteins inhibit HIV-1 release

Marc C. Johnson, E. Freed, P. Rennert, 2014, Proceedings of the National Academy of Sciences.

Evidence of a Role for Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Machinery in HIV-1 Assembly and Release*

E. Freed, H. Garg, A. Joshi, 2011, The Journal of Biological Chemistry.

Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.

S. A. Gallo, Ji Ming Wang, R. Blumenthal, 2004, Virology.

Resistance to Second-Generation HIV-1 Maturation Inhibitors

David E. Martin, S. Durell, E. Freed, 2018, Journal of Virology.

Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain

C. Petropoulos, E. Freed, A. Waheed, 2015, Journal of Virology.

Functional role of Alix in HIV-1 replication.

K. Nagashima, K. Fujii, E. Freed, 2009, Virology.

Inhibition of Human Immunodeficiency Virus Type 1 Assembly and Release by the Cholesterol-Binding Compound Amphotericin B Methyl Ester: Evidence for Vpu Dependence

K. Nagashima, E. Freed, A. Ono, 2008, Journal of Virology.

Inhibition of Human Immunodeﬁciency Virus Type 1 Assembly and Release by the Cholesterol-Binding Compound Amphotericin B Methyl Ester: Evidence for Vpu Dependence (cid:1)

K. Nagashima, E. Freed, A. Waheed, 2008 .

Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane.

T. Veenstra, E. Freed, R. Blumenthal, 2008, Biochemistry.

Elevated Expression of GM3 in Receptor-Bearing Targets Confers Resistance to Human Immunodeficiency Virus Type 1 Fusion

S. A. Gallo, Ji Ming Wang, R. Blumenthal, 2004, Journal of Virology.

Effect of Mutations in the Human Immunodeficiency Virus Type 1 Protease on Cleavage of the gp41 Cytoplasmic Tail

E. Freed, E. Chertova, A. Waheed, 2009, Journal of Virology.

Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells

Ji Ming Wang, R. Blumenthal, F. Ruscetti, 2002, Journal of Virology.

Quenching protein dynamics interferes with HIV capsid maturation

K. Schulten, A. Gronenborn, Peijun Zhang, 2017, Nature Communications.

Late Domain-Dependent Inhibition of Equine Infectious Anemia Virus Budding

E. Freed, R. Montelaro, M. Shehu-Xhilaga, 2004, Journal of Virology.

Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice

A. Steven, E. Freed, J. Fontana, 2015, Journal of Virology.

HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease

E. Freed, E. Chertova, A. Waheed, 2007, Proceedings of the National Academy of Sciences.

Inhibition of HIV-1 Replication by Amphotericin B Methyl Ester

R. Ptak, E. Freed, A. Waheed, 2006, Journal of Biological Chemistry.

Evidence that Productive Human Immunodeficiency Virus Type 1 Assembly Can Occur in an Intracellular Compartment

K. Nagashima, E. Freed, A. Joshi, 2009, Journal of Virology.

The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability.

Indira Hewlett, Jiyang Jiang, Kunio Nagashima, 2011, Virology.

Rab11-FIP1C is dispensable for HIV-1 replication in primary CD4+ T cells but its role is cell-type-dependent in immortalized human T-cell lines

E. Freed, J. Hultquist, S. V. van Engelenburg, 2022, bioRxiv.

Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation

E. Freed, S. Ablan, P. Tedbury, 2015, Proceedings of the National Academy of Sciences.

Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.

K. Nagashima, M. Summers, E. Freed, 2008, Journal of molecular biology.

Enhanced Transmissibility and Decreased Virulence of HIV-1 CRF07_BC May Explain Its Rapid Expansion in China

E. Freed, Shixing Tang, S. Ablan, 2022, Microbiology spectrum.

Real-Time Visualization of HIV-1 GAG Trafficking in Infected Macrophages

K. Nagashima, E. Freed, K. Gousset, 2008, PLoS pathogens.

Distribution of ESCRT Machinery at HIV Assembly Sites Reveals Virus Scaffolding of ESCRT Subunits

Prabuddha Sengupta, Harald F. Hess, Jennifer Lippincott-Schwartz, 2014, Science.

Regulation of Human Immunodeficiency Virus Type 1 Env-Mediated Membrane Fusion by Viral Protease Activity

E. Freed, Yuetsu Tanaka, S. Ablan, 2004, Journal of Virology.

1 1 2 EVIDENCE THAT PRODUCTIVE HUMAN IMMUNODEFICIENCY VIRUS 3 TYPE 1 ASSEMBLY CAN OCCUR IN AN INTRACELLULAR 4 COMPARTMENT 5 6 7

K. Nagashima, E. Freed, A. Joshi, 2009 .

Impact of Human Immunodeﬁciency Virus Type 1 Resistance to Protease Inhibitors on Evolution of Resistance to the Maturation Inhibitor Bevirimat (PA-457) (cid:1) †

E. Freed, Kayoko Waki, K. Salzwedel, 2009 .

Functional Replacement of a Retroviral Late Domain by Ubiquitin Fusion

K. Nagashima, E. Freed, A. Joshi, 2008, Traffic.

Structural basis of HIV-1 maturation inhibitor binding and activity

A. Gronenborn, E. Freed, J. Perilla, 2022, bioRxiv.

In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)

Kunio Nagashima, K. Nagashima, E. Freed, 2006, Journal of Virology.

Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors

David E. Martin, E. Freed, J. Schneider, 2015, Antimicrobial Agents and Chemotherapy.

Global Rescue of Defects in HIV-1 Envelope Glycoprotein Incorporation: Implications for Matrix Structure

E. Freed, S. Ablan, P. Tedbury, 2013, PLoS pathogens.

MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production

Antony K. Chen, J. Lippincott-Schwartz, P. Sengupta, 2014, Proceedings of the National Academy of Sciences.

A Triazinone Derivative Inhibits HIV‐1 Replication by Interfering with Reverse Transcriptase Activity

E. Freed, Kosuke Miyauchi, T. Hoshino, 2016, ChemMedChem.

Elucidation of the Molecular Consequences of Two Unique p6Gag Mutations Derived from HIV-1 CRF07_BC-infected Patients

E. Freed, Shixing Tang, S. Ablan, 2020 .

Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy.

K. Nagashima, E. Freed, H. Garg, 2011, Virology.

The Effect of Inositol Hexakisphosphate on HIV-1 Particle Production and Infectivity can be Modulated by Mutations that Affect the Stability of the Immature Gag Lattice.

A. Saiardi, Peijun Zhang, E. Freed, 2023, Journal of molecular biology.

Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release.

E. Freed, H. Garg, A. Joshi, 2014, The Journal of Biological Chemistry.

Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation

E. Freed, S. Ablan, P. Tedbury, 2015, Proceedings of the National Academy of Sciences.

Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4+ T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines

E. Freed, J. Hultquist, D. Scheiblin, 2022, Journal of virology.